about
Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancerArray-based genome-wide RNAi screening to identify shRNAs that enhance p53-related apoptosis in human cancer cellsA novel method, digital genome scanning detects KRAS gene amplification in gastric cancers: involvement of overexpressed wild-type KRAS in downstream signaling and cancer cell growthAKR1B10, a transcriptional target of p53, is downregulated in colorectal cancers associated with poor prognosis.p53 mediates the suppression of cancer cell invasion by inducing LIMA1/EPLIN.CRKL oncogene is downregulated by p53 through miR-200sLong non-coding RNA NEAT1 is a transcriptional target of p53 and modulates p53-induced transactivation and tumor-suppressor function.Contextual niche signals towards colorectal tumor progression by mesenchymal stem cell in the mouse xenograft model.Conditioned mesenchymal stem cells produce pleiotropic gut trophic factors.Forkhead transcription factor FOXF1 is a novel target gene of the p53 family and regulates cancer cell migration and invasiveness.A novel approach to cancer treatment using structural hybrids of the p53 gene family.p53 negatively regulates the hepatoma growth factor HDGF.A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.CHFR, a potential tumor suppressor, downregulates interleukin-8 through the inhibition of NF-kappaB.p53 family members regulate the expression of the apolipoprotein D gene.Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors.Antitumor effect of adenovirus-mediated p53 family gene transfer on osteosarcoma cell lines.Involvement of splicing factor-1 in beta-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing.Beta-catenin interacts with the FUS proto-oncogene product and regulates pre-mRNA splicing.Alternative splice variant of actinin-4 in small cell lung cancer.Profiling cancer-related gene mutations in oral squamous cell carcinoma from Japanese patients by targeted amplicon sequencing.Identification and characterization of the intercellular adhesion molecule-2 gene as a novel p53 target.Fledglings in p53 signaling network.Overexpression of BAD preferentially augments anoikis.Identification and characterization of a metastatic suppressor BRMS1L as a target gene of p53.HSP72 functionally inhibits the anti-neoplastic effects of HDAC inhibitors.Identification and analysis of large intergenic non-coding RNAs regulated by p53 family members through a genome-wide analysis of p53-binding sites.Mesenchymal stem cells cancel azoxymethane-induced tumor initiation.Poly(ADP-ribose) polymerase-1 is a component of the oncogenic T-cell factor-4/beta-catenin complex.Screening for long noncoding RNAs associated with oral squamous cell carcinoma reveals the potentially oncogenic actions of DLEU1Targeted next-generation sequencing of 50 cancer-related genes in Japanese patients with oral squamous cell carcinomaGenetic analyses of mosaic neurofibromatosis type 1 with giant café-au-lait macule, plexiform neurofibroma and multiple melanocytic nevip53-induced ARVCF modulates the splicing landscape and supports the tumor suppressive function of p53Renal angiomyolipoma (AML) harboring a missense mutation of TSC2 with copy-neutral loss of heterozygosity (CN-LOH)High filamin-C expression predicts enhanced invasiveness and poor outcome in glioblastoma multiformePrognostic Effect of Long Noncoding RNA NEAT1 Expression Depends on p53 Mutation Status in CancerCorrigendum to "Prognostic Effect of Long Noncoding RNA NEAT1 Expression Depends on p53 Mutation Status in Cancer"Correlation between PCR Examination Rate among the Population and the Containment of Pandemic of COVID-19
P50
Q28506447-23EE56A3-7D9D-43C9-B91C-4A184643C55CQ34365770-2206B24F-D381-49B2-A510-82331FFBE6E8Q37281454-95245F76-DDA9-4683-A506-546AB0E4276EQ38311824-F870BBAD-2BC7-4992-983C-F16804DBB565Q38721089-787801C9-F14F-4E59-B4E4-512D2F83E233Q38863620-6955F715-22DE-4FB5-8B88-02244CC0045DQ38907013-188FCBC9-FB03-493C-980A-694CE93222FAQ38909863-E464DD72-9B67-4B7B-8343-0876B5BF71C8Q39064337-997F15F6-6E1D-456D-808A-2A5818B1DBC7Q39067507-7FC50CC7-396A-468C-AF47-2E29876C0493Q39283910-58683CCF-2527-4BBD-ABFC-69AADAE3A267Q39456576-F9D51ED5-2C64-428B-8357-4994358EB32BQ39848864-A77E3055-7460-41E5-8E79-26C930BF8291Q39850171-5D65896C-24DC-476C-B08D-EF48716B041EQ39918840-9A5CB98D-FE5D-4807-9154-DD647FD34D17Q40098270-7DBA33E5-D409-4127-BC4E-CC47FDE2700FQ40120002-7AAD820E-5707-437D-81E4-14E62AC4F17BQ40154769-5BA19606-0B71-4BE4-BF1E-C0EC63CEBC54Q40361099-5456F274-2BDB-41C8-9BA0-A2DA47D178C1Q40560312-5D9BEE25-CF1B-4E02-AB71-0AB3944CDEC3Q41709025-475134C2-9F47-4E5F-BA57-C7D4C9C62D84Q41854551-E7A128C3-DCD7-40F0-83D6-416B07723258Q42357160-99716FAE-F19B-4089-839A-8817CEAE98AFQ44569593-17110924-F88F-45AA-A13F-DD66B64F04BEQ47129006-14C2072B-E612-4D3E-8918-8D1972C2C54CQ50208454-67748C18-49CB-4657-BC25-9F633F0A6DEBQ51524355-8B3D78BA-2260-409D-B92D-5B196EB59797Q53058826-5BD5ABDD-15C1-48BC-A113-F8440381369AQ54660344-CCAB9B1A-F8B7-4DD2-9628-2807EC6B5744Q90699354-6AE58185-27F5-4D80-A718-50D9E4739655Q91502689-504DEE55-A850-4663-BD93-DE4B608D06A4Q91559218-27299D68-076E-4A3E-9B21-209E7D4D78B1Q91892196-1E977AA6-02AA-4CC9-94AD-52BEE3567E2DQ92053899-4ABAE4E5-6653-4DC2-96D0-328843A0D920Q92341877-245CB277-11AA-4B67-9573-06132C743FB4Q92668678-E7D839D4-CFAA-4EE6-B10E-79C47176D064Q93108216-481840A0-FC9D-4FA9-B3A1-4FAE3BC89496Q95600717-8024FE39-DF37-4D42-B4BF-5BF4FBF4A9A1
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Masashi Idogawa
@ast
Masashi Idogawa
@en
Masashi Idogawa
@es
Masashi Idogawa
@nl
type
label
Masashi Idogawa
@ast
Masashi Idogawa
@en
Masashi Idogawa
@es
Masashi Idogawa
@nl
prefLabel
Masashi Idogawa
@ast
Masashi Idogawa
@en
Masashi Idogawa
@es
Masashi Idogawa
@nl
P106
P31
P496
0000-0002-8507-1726